1 – 10 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction : The AD-RIDDLE Project
Malzbender, K. ; Barbarino, P. ; Ferrell, P. Barkman ; Bradshaw, A. ; Brookes, A. J. ; Díaz, C. ; van der Flier, W. M. ; Georges, J. ; Hansson, O. LU
and Hartmanis, M.
, et al.
(2024)
In Journal of Prevention of Alzheimer's Disease
11(2).
p.329-338
- Contribution to journal › Article
- 2021
-
Mark
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
Leuzy, A. LU ; Ashton, N. J. ; Mattsson-Carlgren, N. LU
; Dodich, A.
; Boccardi, M.
; Corre, J.
; Drzezga, A.
; Nordberg, A.
; Ossenkoppele, R.
LU
and Zetterberg, H.
LU
, et al.
(2021)
In European Journal of Nuclear Medicine and Molecular Imaging
48(7).
p.2121-2139
- Contribution to journal › Scientific review
-
Mark
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
Ashton, N. J. ; Leuzy, A. LU ; Karikari, T. K. ; Mattsson-Carlgren, N. LU
; Dodich, A.
; Boccardi, M.
; Corre, J.
; Drzezga, A.
; Nordberg, A.
and Ossenkoppele, R.
LU
, et al.
(2021)
In European Journal of Nuclear Medicine and Molecular Imaging
48(7).
p.2140-2156
- Contribution to journal › Scientific review
-
Mark
Brain injury markers in blood associate with generalised oedema on computed tomography after cardiac arrest
Lagebrant, Alice LU
; Lang, M.
; Mattsson-Carlgren, Niklas
LU
; Blennow, K.
; Dankiewicz, Josef
LU
; Friberg, Hans
LU
; Christian, H
; Horn, J.
; Kjaergaard, J
and Kuiper, Michael
, et al.
(2021)
European Society of Intensive Care Medicine LIVES 2021
p.203-204
- Contribution to conference › Abstract
- 2020
-
Mark
Quantification of total apolipoprotein e and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
Minta, K. ; Brinkmalm, G. ; Janelidze, S. LU ; Sjödin, S. ; Portelius, E. ; Stomrud, E. LU
; Zetterberg, H.
LU
; Blennow, K.
LU
; Hansson, O.
LU
and Andreasson, U.
(2020)
In Alzheimer's Research and Therapy
12(1).
- Contribution to journal › Article
- 2019
-
Mark
Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis
Santillo, A. F. LU
; Lundgren, S.
; Xu, C.
; Orhan, F.
; Fatouros-Bergman, H.
; Blennow, K.
LU
; Zetterberg, H.
LU
; Portelius, E.
; Cervenka, S.
and Jönsson, E. G.
, et al.
(2019)
In Schizophrenia Research
208.
p.490-492
- Contribution to journal › Letter
- 2017
-
Mark
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Johansson, Per LU
; Almqvist, E G
; Wallin, A
; Johansson, J-O
; Andreasson, U
; Blennow, K
; Zetterberg, H
and Svensson, J
(2017)
In PLoS ONE
12(5).
- Contribution to journal › Article
- 2016
-
Mark
Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
- Contribution to journal › Article
-
Mark
Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease
Horvath, I. ; Jia, X. ; Johansson, Per LU
; Wang, C.
; Moskalenko, R.
; Steinau, A.
; Forsgren, L.
; Wågberg, T.
; Svensson, J.
and Zetterberg, H.
, et al.
(2016)
In ACS Chemical Neuroscience
7(1).
p.34-39
- Contribution to journal › Article
-
Mark
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
- Contribution to journal › Article